Paloma Partners Management Co Acquires 215 Shares of Humana Inc. (NYSE:HUM)

Paloma Partners Management Co lifted its holdings in Humana Inc. (NYSE:HUM) by 33.7% during the third quarter, HoldingsChannel.com reports. The firm owned 853 shares of the insurance provider’s stock after purchasing an additional 215 shares during the period. Paloma Partners Management Co’s holdings in Humana were worth $270,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in HUM. Creative Financial Designs Inc. ADV lifted its position in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. increased its position in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. Atwood & Palmer Inc. bought a new stake in Humana during the third quarter worth about $29,000. Ashton Thomas Securities LLC acquired a new position in Humana during the third quarter valued at approximately $31,000. Finally, Your Advocates Ltd. LLP grew its stake in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Stephens reissued an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Barclays boosted their price objective on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and cut their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Finally, Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and lifted their price target for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Price Performance

Shares of Humana stock opened at $283.06 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $34.08 billion, a price-to-earnings ratio of 25.07, a price-to-earnings-growth ratio of 2.29 and a beta of 0.53. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $498.17. The company has a 50-day simple moving average of $273.44 and a two-hundred day simple moving average of $327.75.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Analysts forecast that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.25%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is currently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.